This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
large-cap: Archive
Anatomy of a Trade: 3 Key Considerations for Buying a Stock
by Ethan Feller
There is no way around the fact that trading and investing is a challenging and complex endeavor but that doesnt mean buying stocks cant be made simple
BRK.BPositive Net Change MGMNegative Net Change
gaming large-cap
Dividend Watch: 3 Companies Boosting Payouts
by Derek Lewis
Dividend increases are a reassuring announcement that shareholders can receive, indicating that business is sound. After all, if a company is struggling, why would it raise its dividend?
AAPLPositive Net Change COSTPositive Net Change
dividends finance large-cap retail tech-stocks
Time to Invest in the Growth of FinTech?
by Shaun Pruitt
Currently valued at upwards of $200 billion, it would be no surprise if the fintech market becomes a trillion-dollar industry in the distant future as innovation continues among financial services.
MAPositive Net Change VPositive Net Change PYPLNegative Net Change SQPositive Net Change AMZNNegative Net Change EBAYPositive Net Change
banking bitcoin cryptocurrency e-commerce fin-tech finance internet investing large-cap payments software stock-performance tech-stocks
All Eyes on Fed Rate Decision: Key Stocks to Watch
by Bryan Hayes
Given three of the largest U.S. bank failures in recent months, will the Fed stay the course?
JPMPositive Net Change AAPLPositive Net Change AMDNegative Net Change RUTHPositive Net Change WALNegative Net Change FRCPositive Net Change PACWPositive Net Change WINGNegative Net Change KRENegative Net Change
consumer-discretionary earnings etfs fang inflation interest-rate investing large-cap restaurants retail semiconductor tech-stocks
2 Diverse Stocks to Buy on the Earnings Beat
by Shaun Pruitt
The strong quarterly results are a good sign that there could be more upside in General Electric and Kimberly-Clark stock this year.
GEPositive Net Change KMBNegative Net Change
consumer-staples earnings investing large-cap multi-sector-conglomerates
Buying Shares Post-Split: Good or Bad Idea?
by Derek Lewis
Interestingly enough, only two of these five stocks reside in the green post-split. Can they keep climbing?
TSLANegative Net Change MNSTPositive Net Change PANWNegative Net Change GOOGLPositive Net Change SHOPNegative Net Change
consumer-staples cybersecurity e-commerce electric-vehicles large-cap tech-stocks
3 Top-Rated Stocks to Buy After Earnings
by Shaun Pruitt
Following their strong quarterly results the rising earnings estimate revisions are a great sign that there could be a nice amount of upside in these top-rated Zacks stocks.
JPMPositive Net Change OMCPositive Net Change LWNegative Net Change
advertising consumer-discretionary consumer-staples earnings finance inflation investing large-cap
Q1 Earnings: Tesla, Netflix On Deck
by Derek Lewis
Earnings season kicked off last week, with several big banks such as JPMorgan, Wells Fargo, and Citigroup getting the party started. And this week, the party continues with several market favorites, including Netflix and Tesla.
WFCNegative Net Change JPMPositive Net Change CNegative Net Change NFLXPositive Net Change TSLANegative Net Change
earnings electric-vehicles large-cap tech-stocks
Time to Buy Stock in These Conglomerates?
by Shaun Pruitt
With their extensive reach, here are three conglomerates' investors may want to consider as they are top-rated Zack stocks at the moment.
GEPositive Net Change DHRNegative Net Change DISPositive Net Change NFLXPositive Net Change
consumer-discretionary investing large-cap multi-sector-conglomerates
5 Diverse Medical Stocks to Buy for 2023 and Beyond
by Shaun Pruitt
The top and bottom-line growth make these Zacks Medical stocks very attractive.
NVOPositive Net Change HUMNegative Net Change CHGCYPositive Net Change HZNPPositive Net Change CSLLYPositive Net Change
biotechnology cancer cell-therapy dividend-investing dividends gene-therapy hmo hospitals immuno-therapy insurance large-cap medical pharmaceuticals vaccines